Oncology Unscripted With John Marshall: Episode 36: What Do Politics, Mergers, and Blood Tests Mean for Cancer Care?
Unable to add items
Add to basket failed.
Add to wishlist failed.
Failed to remove from Wish List.
Adding to library failed
Unable to follow podcast
Unable to unfollow podcast
Oncology Unscripted With John Marshall: Episode 36: What Do Politics, Mergers, and Blood Tests Mean for Cancer Care?
-
Narrated by:
-
By:
Main Topic
In this episode of Oncology Unscripted, Dr John Marshall examines a White House push for final sign-off on NIH grants and what politicizing science could mean for research and health equity in cancer care. He also looks at merger talks between AstraZeneca and Bristol Myers Squibb and weighs both sides of the discussion surrounding blood tests for cancer screening.
MedBuzz
In this MedBuzz, Dr John Marshall reflects on a week of Zoom interviews for a new cancer center director, a head pastor, and fellowship candidates, and on how hard it has become to get butts in chairs at in-person medical meetings and where we go from here.
Interview
In this Candid Conversation, John Marshall, MD, Lucile Adams-Campbell, PhD, and Monica Baskin, PhD, discuss breakthroughs in cancer center leadership, including Dr Baskin becoming the first Black woman to lead a cancer center designated by the National Cancer Institute. They also talk about mentorship, the women who paved the way, and why politics has no place in science.
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
